Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hilgard

Showing results (21-30 of 135) with videos related to

Pageof 14
Sort By:
Cancer Treatment Reviews|September 1, 1990
Oxazaphosphorine toxicity reduction by mesnaP Hilgard, J Pohl
Journal of Cancer Research and Clinical Oncology|January 1, 1981
Anticoagulants and experimental metastases-evaluation of antimetastatic effects in different model systemsB Maat, P Hilgard
Investigational New Drugs|January 1, 1986
Cause and prevention of mafosfamide-induced venous painP Hilgard, J Pohl
Pathologie-Biologie|December 1, 1982
[Development and dissemination of malignant tumors and hemostasis]A Kher, P Hilgard
Lancet (London, England)|January 1, 1979
Synthesis of procoagulant antihaemophilic factor in vitroD Mohanty, P Hilgard
European Journal of Cancer & Clinical Oncology|November 1, 1984
Sodium-2-mercaptoethanesulfonate (MESNA) and ifosfamide nephrotoxicityP Hilgard, H Burkert
European Journal of Cancer|April 1, 1970
Fibrinolysis, thromboplastin activity and localization of radioiodinated fibrinogen in experimental tumorsP Hilgard, V Hiemeyer
Lymphology|December 1, 1972
Activation of fibrinolysis by a lymphogenic activator in the ratP Hilgard, R Hohage
Lancet (London, England)|December 30, 1972
Aspirin and tumour metastasisS Wood, P Hilgard
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|April 28, 1983
[Development and dissemination of malignant tumors, and hemostasis]A Kher, P Hilgard
Pageof 14

Showing results (21-30 of 135) with videos related to

Sort By:
Pageof 14
Cancer Treatment Reviews|September 1, 1990
Oxazaphosphorine toxicity reduction by mesnaP Hilgard, J Pohl
Journal of Cancer Research and Clinical Oncology|January 1, 1981
Anticoagulants and experimental metastases-evaluation of antimetastatic effects in different model systemsB Maat, P Hilgard
Investigational New Drugs|January 1, 1986
Cause and prevention of mafosfamide-induced venous painP Hilgard, J Pohl
Pathologie-Biologie|December 1, 1982
[Development and dissemination of malignant tumors and hemostasis]A Kher, P Hilgard
Lancet (London, England)|January 1, 1979
Synthesis of procoagulant antihaemophilic factor in vitroD Mohanty, P Hilgard
European Journal of Cancer & Clinical Oncology|November 1, 1984
Sodium-2-mercaptoethanesulfonate (MESNA) and ifosfamide nephrotoxicityP Hilgard, H Burkert
European Journal of Cancer|April 1, 1970
Fibrinolysis, thromboplastin activity and localization of radioiodinated fibrinogen in experimental tumorsP Hilgard, V Hiemeyer
Lymphology|December 1, 1972
Activation of fibrinolysis by a lymphogenic activator in the ratP Hilgard, R Hohage
Lancet (London, England)|December 30, 1972
Aspirin and tumour metastasisS Wood, P Hilgard
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|April 28, 1983
[Development and dissemination of malignant tumors, and hemostasis]A Kher, P Hilgard
Pageof 14